|
|
|
Volumn 40, Issue 4, 2006, Pages 7-
|
|
MS drug back on market under restricted program.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
NATALIZUMAB;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEUKOENCEPHALOPATHY;
MULTIPLE SCLEROSIS;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
DRUG APPROVAL;
HUMANS;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
MULTIPLE SCLEROSIS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 39049177135
PISSN: 03621332
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|